TY - JOUR T1 - A fundamental model and predictions for the spread of the COVID-19 epidemic JF - medRxiv DO - 10.1101/2020.04.27.20081281 SP - 2020.04.27.20081281 AU - Baolian Cheng AU - Yi-Ming Wang Y1 - 2020/01/01 UR - http://medrxiv.org/content/early/2020/05/01/2020.04.27.20081281.abstract N2 - The spread of the novel coronavirus is characterized by two phases: (I) a natural exponential growth phase that occurs in the absence of intervention and (II) a regulated growth phase that is affected by enforcing social distancing and isolation. We have developed a fundamental spreading model for the COVID-19 epidemic that has two parameters: the community transmission rate and a metric describing the degree of isolation and social distancing in a given community or region (country, state, county, or city). These two parameters are calibrated to data from the community, so the model uncertainty depends on the quality of the data and ability to test for COVID-19. The model shows that social distancing significantly reduces the epidemic spread and flattens the curve. The model predicts well the spreading trajectory and peak time of new infections for a community of any size and provides an upper estimate for the total number of infections and daily new infection rate for weeks into the future, providing the vital information and lead time needed to prepare for and mitigate the epidemic. The theory has immediate and far-reaching applications for ongoing outbreaks or similar future outbreaks of other emergent infectious diseases (LA-UR-20–22877).Disclaimer This material is not final and is subject to be updated any time. Contact information: bcheng{at}lanl.gov.Competing Interest StatementThe authors have declared no competing interest.Funding StatementB.C. was supported under the auspices of the U.S. Department of Energy by the Los Alamos National Laboratory under Contract No. 89233218CNA000001. Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCode used will be made available as soon as possible. ER -